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 The use of extracorporeal membrane oxygenation (ECMO) 
to treat severe adult cardiac and respiratory failure has 
increased in the past decade. Advances in the technology 
relating to ECMO,1 supportive evidence,2-4 and greater 
clinical experience5 have all contributed to increasing 
activity in the area of ECMO. Despite these factors, ECMO 
remains a complex therapy with use restricted to very few 
patients in the intensive care unit.
At present, ECMO is provided mostly in specialised 
metropolitan hospitals with annual caseloads of greater 
than 30 ECMO patients.6-9 Survival rates for patients 
receiving ECMO appear to be higher in institutions that use 
this therapy more frequently,9-11 but there are many factors 
confounding this observation (such as patient selection 
bias, timing bias and resource bias). The role of adult ECMO 
in centres managing lower numbers of patients receiving 
ECMO remains unclear.
A robust service delivery model is likely to make the 
provision of ECMO safer in centres managing lower 
numbers of patients.12,13 Key factors include a clear clinical 
governance structure, ongoing training, accreditation, 
maintenance of standards, sustainable program delivery 
and consideration of the caseload required to maintain 
profi ciency.6-8,10,12-16
Because of the expanding role of ECMO in critical care, we 
developed a service delivery model at our tertiary regional 
hospital, where we had previously managed a low volume 
of patients receiving ECMO. We describe the components 
of our program and report characteristics, annual caseload, 
circuit confi guration, complications and survival of patients 
supported on ECMO, before and after implementation of 
the new service model.
Methods
Setting
The University Hospital Geelong (UHG) ICU is a regional, 
level 3 ICU with 24 adult beds. It is a mixed medical, 
surgical, cardiothoracic and level 2 paediatric unit with over 
1700 admissions and 450 cardiac surgical cases annually. 
It services a population of about 500 000 people in the 
Barwon South-Western region of Victoria, Australia.
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ABSTRACT
Background:  The role of extracorporeal membrane 
oxygenation (ECMO) for adults in regional centres with low 
numbers of patients receiving ECMO is unclear. A robust 
service delivery model may assist in the quality provision of 
ECMO.
Objective: To describe a novel ECMO service delivery 
model in a regional Australian hospital, reporting on 
patient characteristics and outcomes before and after its 
implementation.
Methods: An observational cohort study of all patients 
receiving ECMO at the University Hospital Geelong 
intensive care unit before and after implementation of a 
new ECMO clinical service model. The program included 
intensivist training in cannulation and care for ECMO 
patients, nurse accreditation in ECMO maintenance, and 
establishing a relationship with an ECMO centre caring for 
a high number of patients. Data included ECMO caseload, 
circuit confi guration, complications, durations of therapy, 
and survival to ECMO weaning and ICU and hospital 
discharge.
Results: During the 14-year period for which we collected 
data, 61 adults received ECMO: 21 (35%) before and 40 
(65%) after implementation of the structured program. 
The median annual case rate increased signifi cantly 
between periods from two (range, 0–5 cases) to 10 
(range, 5–13 cases) (P < 0.01). Other changes from 
before to after implementation included more medical 
indications for ECMO (48% v 80%; P < 0.01), higher 
peripheral cannulation confi guration (57% v 98%; P 
< 0.01) and greater intensivist involvement as cannulation 
proceduralists (29% v 80%; P < 0.01). There were no 
signifi cant differences between cohorts in ECMO weaning 
or duration, complication rates or ICU or in-hospital 
mortality. 
Conclusions: Provision of ECMO in a tertiary regional 
hospital within a multifaceted clinical service model is 
feasible and safe. Partnership with a centre providing 
ECMO for a high number of patients during service 
development and delivery is desirable.
Crit Care Resusc 2016; 18: 235-241
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Patients
The fi rst patient managed with ECMO at UHG was in 2002, 
and its use was sporadic over the ensuing 9 years. During 
this period, cardiac surgeons inserted most ECMO cannulae, 
and a perfusionist was required to continuously monitor for 
circuit complications. This model resulted in the frequent 
cancellation of cardiac surgical cases and early interhospital 
transfer of patients from UHG. Intensivists at UHG had 
variable experience with ECMO, and clinical advice was 
routinely sought from a high-volume ECMO centre, The 
Alfred Hospital ICU (Melbourne, Victoria).
ECMO service delivery model
We developed a new clinical service model for ECMO over 
36 months in consultation with intensivists, ICU nursing 
staff, cardiothoracic surgeons, perfusionists, and The Alfred 
Hospital ICU staff. This new program was implemented in 
May 2011.
Our model involves a formal approach to education, 
accreditation, cannulation and the management of ECMO 
hardware and circuitry. Management protocols were 
established in alignment with both The Alfred Hospital17 
and international ECMO guidelines.15
The ECMO initiation procedure was changed to occur 
principally in the ICU, and required a minimum of three 
intensivists: two for cannulation and one to provide 
echocardiographic support. A perfusionist was required 
to initiate ECMO and thereafter reviewed the circuit twice 
daily and remained on call to provide emergency assistance 
until successful weaning from ECMO had occurred. Two 
ICU nurses were allocated to each patient: one accredited 
to manage the ECMO circuit, and a second for routine 
patient care. In the event of two patients supported on 
ECMO simultaneously, one accredited nurse would manage 
both circuits. 
Videoconference facilities were introduced for case 
discussion between hospitals, cardiac surgical staffi ng was 
changed and ECMO equipment was upgraded to align 
with the pump and circuitry used at The Alfred Hospital 
(CardioHelp HLS set 7.0, Maquet).
Service monitoring
We developed an ECMO database to prospectively collect 
patient demographic data, indications for ECMO, treatment 
confi guration, complications, lengths of stay and mortality. 
To monitor activity and outcomes after the introduction 
of the new service, data from all patients receiving ECMO 
before May 2011 were retrospectively added to the 
database.
We undertook a cohort study of all adult patients 
receiving ECMO at UHG before the introduction of the new 
clinical service model (January 2002 – April 2011) and after 
its introduction (May 2011 – December 2015). Our aim was 
to monitor the safety of the new program and identify any 
trends in ECMO use over time. We sought to determine 
the number of patients receiving ECMO, the circuit 
confi gurations, complications, durations of therapy, and 
survival to ECMO weaning and ICU and hospital discharge. 
We tested differences between cohorts with the Wilcoxon 
rank-sum test for continuous variables, and with the Fisher 
exact test for binary outcomes, using R software (R Core 
Team).
The Barwon Health Research Ethics Committee approved 
our data collection and waived the requirement for patient 
consent.
Results
Patient characteristics and caseload 
During the 14-year period, a total of 61 patients received 
ECMO: 21 (35%) before and 40 (65%) after the introduction 
of the structured program. The median annual case rate 
increased signifi cantly between periods, from two cases 
(range, 0–5 cases) to 10 cases (range, 5–13 cases) per year 
(P < 0.01) (Figure 1). There were no signifi cant differences 
in age, sex, weight or severity of illness between the cohorts 
(Table 1).
Circuit confi guration
Venoarterial (VA) ECMO represented 66% of cases overall, 
with 15 cases (71%) in the before group, and 25 cases 
(63%) in the after group. There were six cases (29%) of 
venovenous (VV) ECMO over the 9-year before period, 
which increased to 15 cases (37%) in the 4.5-year after 
period. ECMO confi guration (VV or VA) did not differ 
signifi cantly between groups (Table 1).
Indications for ECMO 
After introduction of the new program, a signifi cantly 
greater proportion of patients received VA ECMO after 
admission to ICU with a medical diagnosis (before program, 
48% v after program, 80%), and a lower proportion 
received ECMO after cardiac surgery (before program, 52% 
v after program, 15%; P < 0.01). This was associated with a 
signifi cant increase in patients with cardiogenic shock after 
myocardial infarction receiving ECMO (before program, 
4.8% v after program, 30%; P < 0.01) (Table 2).
Cannulation
Intensivists performed signifi cantly more cannulations in the 
ICU after introduction of the new service (before program, 
29% v after program, 80%; P < 0.01). The number of 
central cannulations also declined signifi cantly (before, 
43% v after, 3%; P < 0.01) (Table 1).
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Duration of therapy
The duration of each ECMO treatment did not differ 
signifi cantly between cohorts (3.6 v 5.1 days; P = 0.50), 
but a signifi cantly longer hospital length of stay (16 v 28.6 
days; P = 0.04), and trend towards a longer ICU length of 
stay (8.2 v 16.3 days; P = 0.06), was observed following 
implementation of the new service (Table 1). 
The overall proportion of patients on ECMO transferred 
to another hospital was not signifi cantly different between 
time periods (before, 33% v after, 18%; P = 0.21). However, 
subgroup analysis of VV ECMO cases revealed a signifi cant 
reduction in transfer rates following introduction of the 
new program (before, 66% v after, 7%; P = 0.01) (Table 3).
Complications 
The overall complication rates between groups were similar 
(Table 4). Mechanical complications involving ECMO circuitry 
were signifi cantly less frequent after implementation of 
the new service (33% v 6%; P < 0.02). There were no 
differences in the rates of major bleeding (40% v 17%; 
P = 0.08) or technical complications, including diffi cult or 
failed cannulations, vascular damage requiring surgical 
intervention, or changes to circuit confi guration after start 
of ECMO (27% v 34%; P = 0.75).
Outcomes 
Survival to ECMO weaning did not differ between cohorts 
(before program, 52% v after program, 74%; P = 0.10), 
and nor did survival to ICU or hospital discharge (before 
program, 38% v after program, 56%; P = 0.28). No patient 
died in hospital after successful ECMO weaning and ICU 
discharge. The cumulative caseload and hospital survival is 
depicted in Figure 2.
Discussion
Major fi ndings
We describe the key features, demographics and outcomes 
before and after the introduction of a structured ECMO 
program in a tertiary regional hospital. The program 
was associated with a fi vefold increase in annual ECMO 
caseload, more medical indications for ECMO, greater 
intensivist involvement in cannulation, and fewer VV ECMO 
patients requiring interhospital transfer. There were no 
signifi cant differences in survival or adverse events. These 
data are supportive of the conclusion that an ECMO service 
can be safely provided in a regional hospital.
Figure 1. Annual ECMO caseload and successful weaning, 2002 to 2016
ECMO = extracorporeal membrane oxygenation. UHG = University Hospital Geelong.
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Table 1. Patient, clinical and outcome 
characteristics before and after start of 
structured ECMO program
Characteristic Before (n = 21) After (n = 40) P
Median cases   2 (1.0–4.0)  10 (5.0–10.0) < 0.01
per year,* (IQR) 
Demographic variable   
Median age,  53.0  57.0 0.90
years (IQR) (35.0–64.0)  (38.0–63.0)  
Women, n (%) 8 (38.1%)  8 (20.0%)  0.14
Median weight,  87  88.5 0.41
kg (IQR) (70.0–97.0) (75.0–110.0) 
Admission category, n (%)    < 0.001
Medical† 10 (47.6%) 32 (80.0%) 
Surgical 0 2 (5.0%) 
Cardiothoracic 11 (52.4%) 6 (15.0%) 
Critical illness-related   
Median APACHE II  21.0 20.5 0.93
score‡ (IQR) (18.0–24.0)  (16.0–29.3)  
Median SOFA  16.0 14.0 0.09
score§ (IQR) (14.5–18.0)  (12.5–16.0) 
CRRT used,¶ n (%)  8 (38.1%)  25 (62.5%)  0.10
Catecholamines  20 (95.2%)  40 (100%)  0.34
used,¶ n (%) 
ECMO confi guration, n (%)   0.58
Venoarterial 15 (71.4%) 25 (62.5%) 
Venovenous 6 (28.5%) 15 (37.5%) 
Cannulation, n (%)   < 0.01
Peripheral 12 (57.1%) 39 (97.5%) 
Central 9 (42.9%) 1 (2.5%) 
Cannulator, n (%)   < 0.01
Intensivist 6 (28.6%) 32 (80.0%) 
Cardiac surgeon 15 (71.4%) 8 (20.0%) 
Outcome   
Median ECMO  3.6 5.1 0.50
duration, days (IQR) (1.9–9.2)  (3.0–9.0) 
Median ICU LOS,  8.2 16.3 0.06
days (IQR) (2.8–17.6) (6.5–26.2)
Median hospital LOS,  16 28.6 0.04
days (IQR) (6.3–21.7) (6.6–41.3) 
Transfer, n (%) 7 (33.3%) 7 (18.0%) 0.21
ECMO survival, n (%) 11 (52.4%) 29 (74.3%) 0.10
ICU survival, n (%) 8 (38.1%) 22 (56.4%) 0.28
Hospital survival, n (%) 8 (38.1%) 22 (56.4%) 0.28
ECMO = extracorporeal membrane oxygenation. IQR = interquartile 
range. APACHE = Acute Physiology and Chronic Health Evaluation. 
SO-FA = Sequential Organ Failure Score. CRRT = continuous renal 
replacement therapy. ICU = intensive care unit. LOS = length of stay. 
* Adjusted to account for the periods before and after introduction of 
new program in 2011: actual caseload before program introduction 
(Jan–Apr 2011) was 2; actual caseload after program introduction 
(May–Dec 2011) was 7. † Defi ned as any indication for ECMO not 
directly resulting from a surgical procedure. ‡ Based on diagnosis 
at admission. § Worst values calculated within 24 hours before 
cannulation. ¶ Treatment provided while patient receiving ECMO.
Table 2. Demographic, clinical, indication and 
outcome characteristics for patients receiving 
VA ECMO, before and after start of structured 
ECMO program
Characteristic Before (n = 15) After (n = 25) P
Median cases  1.5 (1.0–2.8) 6.0 (4.0–6.0) < 0.01
per year,* (IQR) 
Demographic variable   
Median age,  63.0  59 0.50
years (IQR) (48.0–68.5) (52.0–67.0) 
Women, n (%) 4 (26.7%) 2 (8.0%) 0.39
Median weight,  90 81 0.86
kg (IQR)  (72.5–101.0) (75.0–100.0) 
Critical illness-related   
Median APACHE II  22.0 26.0 0.52
score† (IQR) (18.5–24.0) (18.0–30.0) 
Median SOFA  16 14.0 0.30
score‡ (IQR) (14.5–18.0) (13.0–16.8) 
CRRT used,§ n (%)  6 (40.0%) 17 (68.0%) 0.33
Catecholamines  15 (100%) 25 (100%) 1.0
used,§ n (%) 
Indication, n (%)   
Post-cardiotomy  10 (47.6%) 5 (12.5%) < 0.01
Cardiogenic shock 1 (4.8%) 12 (30.0%) 0.01
Cardiomyopathy 4 (19.0%) 8 (20.0%)  0.72
Cannulation, n (%)   < 0.01
Peripheral 9 (60.0%) 24 (96.0%) 
Central 6 (40.0%) 1 (4.0%) 
Cannulator, n (%)   < 0.01
Intensivist 2 (13.3%) 17 (68.0%) 
Cardiac surgeon 13 (86.7%) 8 (32.0%) 
Outcome   
Median ECMO  3.4 4.2 0.48
duration, days (IQR) (1.3–5.9) (2.3–5.7) 
Median ICU LOS,  5.8 11.9 0.09
days (IQR)  (2.5–13.5) (4.8–26.4) 
Median hospital LOS,  10.3 27.0  0.20
days (IQR) (5.1–18.8) (4.9–44.7) 
Transfer, n (%) 3 (20.0%) 6 (25.0%) 1
ECMO survival, n (%) 8 (53.3%) 19 (79.0%)  0.19
ICU survival, n (%) 5 (33.3%) 12 (50.0%)  0.52
Hospital survival,  5 (33.3%) 12 (50.0%)  0.52
n (%) 
VA = venoarterial. ECMO = extracorporeal membrane oxygenation. 
IQR = interquartile range. APACHE = Acute Physiology and Chronic 
Health Evaluation. SOFA = Sequential Organ Failure Score. CRRT = 
continuous renal replacement therapy. ICU = intensive care unit. 
LOS = length of stay. * Adjusted to account for the periods before 
and after introduction of new program in 2011: actual caseload 
before program introduction (Jan–Apr 2011) was 2; actual caseload 
after program introduction (May–Dec 2011) was 6. † Based on 
diagnosis at admission. ‡ Worst values calculated within 24 hours 
before cannulation. § Treatment provided while patient receiving 
ECMO.
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Comparison with previous studies
As far as we are aware, this is the fi rst study to describe the 
establishment of a structured ECMO service and outcomes 
in a regional centre. The complication rates and outcomes 
of this service are in keeping with similar programs 
worldwide,6,16,18 and compare favourably with results 
reported by the Extracorporeal Life Support Organization 
(ELSO) adult international summary.5
The role of ECMO in low-volume centres has been 
questioned.9-12 A retrospective analysis of more than 10 000 
adults on the ELSO registry categorised units according 
to their annual ECMO caseload.9 Mortality was inversely 
proportional to volume, with the highest recorded mortality 
rates occurring in units with fewer than six cases per year. 
Since the introduction of our structured ECMO program, 
our median unit volume has increased from fewer than 
fi ve cases per year to 10 cases per year (low-to-moderate 
volume category). Our mortality rate during this period 
was similar to that of high-volume centres managing more 
than 30 cases per year,9 and our complication rates were 
comparable to those recorded in the ELSO registry.18 Models 
describing ICU-led services, specifi cally the use of intensivists 
and nursing staff as cannulators and ECMO specialists in 
high-volume centres, report outcomes suggesting that they 
are safe, feasible and cost-effective.6,16,19,20 Our results 
add to this literature by reporting similar outcomes with 
a model of ICU-led ECMO delivery in a low-to-moderate 
volume regional centre with formal support from a high-
volume centre.
Implications for clinicians and policy makers
We believe several elements assisted in the transition, 
maintenance of standards and safe outcomes after the 
Table 3. Demographic, clinical, indication and 
outcome characteristics for patients receiving 
VV ECMO, before and after start of structured 
program
Characteristic Before (n = 6) After (n = 15) P
Median cases per year,*  0 2.0 0.03
(IQR) (0–1.0) (1.5–4.0)  
Demographic variable   
Median age,  31.5  52.0 0.08
years (IQR) (25.8–35.8) (31.0–58.0) 
Women, n (%) 4 (66.7%) 6 (40.0%) 0.36
Median weight,  80 95 0.20
kg (IQR) (72.5–92.8) (76–128.5) 
Critical illness-related   
Median APACHE II  18.5 17.0 0.82
score† (IQR) (16.5–20.5) (12.5–25.0) 
Median SOFA  15.5 13 0.21
score‡ (IQR) (13.5–16.5) (12.0–14.5)  
CRRT used,§ n (%)  2 (33.3%) 10 (66.7%) 0.33
Catecholamines  5 (83.3%) 15 (100%) 0.29
used,§ n (%) 
Indication   
Viral pneumonia  2 (9.5%) 4 (10.0%) 0.57
Bacterial pneumonia 1 (4.8%) 3 (7.5%) 0.77
Aspiration pneumonia 0 2 (5.0%) 
Other¶ 3 (14.3%) 6 (15.0%) 
Cannulation, n (%)   1.0
Peripheral 6 (100%) 15 (100%) 
Central 0 0 
Cannulator, n (%)   0.07
Intensivist 4 (66.7%) 15 (100%) 
Cardiac surgeon 2 (33.3%) 0 
Outcome   
Median ECMO  10.4 8.4 0.61
duration, days (IQR) (4.4–12.0) (4.9–10.3) 
Median ICU LOS,  17.4 20.9 0.51
days (IQR) (14.9–19.1) (11.5–25.4) 
Median hospital LOS,  21.4 30 0.15
days (IQR) (16.5–24.1) (21.0–38.5) 
Transfer, n (%) 4 (66.7%) 1 (7.1%) 0.01
ECMO survival, n (%) 3 (50.0%) 11 (73.3%) 0.35
ICU survival, n (%) 3 (50.0%) 11 (73.3%) 0.35
Hospital survival, n (%) 3 (50.0%) 11 (73.3%) 0.35
VV = venovenous. ECMO = extracorporeal membrane oxygenation. 
IQR = interquartile range. APACHE = Acute Physiology and Chronic 
Health Evaluation. SOFA = Sequential Organ Failure Score. CRRT = 
continuous renal replacement therapy. LOS = length of stay. ICU = 
intensive care unit. * Adjusted to account for the periods before 
and after introduction of new program in 2011: actual caseload 
before program introduction (Jan–Apr 2011) was 0; actual caseload 
after program introduction (May–Dec 2011) was 1. † Based on 
diagnosis at admission. ‡ Worst values calculated within 24 hours 
before cannulation. § Treatment provided while patient receiving 
ECMO. ¶ Including acute respiratory distress syndrome; pulmonary 
embolism; and post-operative, post-traumatic, non-surgical and 
non-traumatic conditions. 
Table 4. Complication rates* of ECMO before and 
after start of structured program,† n (%)
Complication Before (n = 15) After (n = 35) P
Mechanical 5 (33.3%) 2 (6.0%) 0.02
Technical‡ 4 (26.7%) 12 (34.3%) 0.75
Bleeding-related 6 (40.0%) 6 (16.7%) 0.08
CVS-related 3 (20.0%) 0 0.02
CNS-related 2 (13.3%) 1 (2.9%) 
Sepsis 1 (6.7%) 2 (5.7%) 
Metabolic 1 (6.7%) 3 (8.6%) 
Limb-related 1 (6.7%) 5 (14.3%) 0.65
CVS = cardiovascular system. CNS = central nervous system. 
* Calculated as rate per patient-ECMO run (based on guidelines13). 
† Transferred patients excluded unless complications arose before 
transfer. ‡ Including diffi cult cannulation (multiple attempts or 
unable to pass backfl ow cannula), failed cannulation, death on 
cannulation, vascular damage requiring intervention, and changes 
to confi guration after commencement of ECMO (see guidelines13).
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introduction of this new program. These include model type, 
governance structure and partnership with a high-volume 
ECMO centre. These observations are in keeping with previous 
reports,6,8-15 and may inform the debate surrounding 
guidelines on minimum caseloads, organisational structure, 
and the processes of care required to maintain a safe service, 
as recommendations currently vary.12-14
The change in our model type has resulted in other 
advantages, including the ability to care for patients in 
their geographical region, the removal of barriers to the 
timely initiation of ECMO, providing a unit capacity to 
manage multiple ECMO patients concurrently, empowering 
ICU nursing staff in a new technical skill, and allowing 
perfusionists to continue to provide services for cardiac 
surgery while patients are receiving ECMO.
Future research
Telehealth technology has been described in the ICU 
setting,21 and has been shown to be an independent 
predictor of survival when used in remote ICUs.22 Its 
specifi c use in ECMO has not been widely reported until 
now, although it has been shown to enhance care in 
other specialised areas of ICU practice.23 Initially, our 
program relied heavily on videoconferencing, which aided 
the establishment of working relationships and facilitated 
timely discussions on patient 
selection, appropriate mode 
and confi guration of supports, 
retrieval, trouble-shooting and 
weaning strategies.
Strengths and limitations
Our study has various strengths, 
including that it was a prospective 
study examining robust outcome 
measures on all patients who 
received ECMO within our unit, 
with few reported missing data. It 
addresses a topical area of practice 
(concerns regarding ECMO service 
profi ciency and safety in regional 
centres), which was unreported 
in the literature. It also shows 
the feasibility of a model relying 
heavily on telehealth technology 
in partnership with a high-volume 
centre. 
It is important to note that 
we measured only key clinical 
variables directly related to 
ECMO. A limitation of our study 
is that many other clinical service 
changes may have infl uenced our observations. Patient 
selection, management protocols, changes in staff and 
improved outcomes over time may all have infl uenced our 
fi ndings. Although we were able to demonstrate that an ICU 
nurse can be trained to manage an ECMO circuit, we cannot 
determine the cost-effectiveness of this model. A recent 
study suggests that there may be a 60% cost reduction 
when comparing similar models of service described in our 
study.16 Our results are restricted by our small sample size 
but are the largest reported from a regional hospital.
Conclusion
The provision of ECMO in a tertiary regional hospital within 
the construct of a multifaceted clinical service model is 
feasible and safe. Partnership with a high-volume centre 
during service development and delivery is desirable.
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 Figure 2. Cumulative ECMO caseload and hospital survival, 2002–2016
ECMO = extracorporeal membrane oxygenation. UHG = University Hospital Geelong.
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